ScoreWhy is Dr Lal Pathlabs Ltd ?
1
High Management Efficiency with a high ROE of 20.01%
2
The company is Net-Debt Free
3
Poor long term growth as Net Sales has grown by an annual rate of 11.81% and Operating profit at 11.57% over the last 5 years
4
Flat results in Mar 26
- PAT(Q) At Rs 131.30 cr has Fallen at -15.2%
- DEBTORS TURNOVER RATIO(HY) Lowest at 24.96 times
5
With ROE of 21, it has a Very Expensive valuation with a 10.7 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 13.02%, its profits have risen by 8.2% ; the PEG ratio of the company is 6.4
6
High Institutional Holdings at 38.57%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Market Beating performance in long term as well as near term
- Along with generating 13.02% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Dr Lal Pathlabs should be less than 10%
- Overall Portfolio exposure to Healthcare Services should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Dr Lal Pathlabs for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Dr Lal Pathlabs
12.99%
0.46
28.37%
Sensex
-3.33%
-0.25
13.43%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.81%
EBIT Growth (5y)
11.57%
EBIT to Interest (avg)
18.38
Debt to EBITDA (avg)
0.44
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
1.08
Tax Ratio
23.81%
Dividend Payout Ratio
42.00%
Pledged Shares
0
Institutional Holding
38.57%
ROCE (avg)
53.14%
ROE (avg)
20.01%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
51
Industry P/E
61
Price to Book Value
10.67
EV to EBIT
41.30
EV to EBITDA
32.76
EV to Capital Employed
18.64
EV to Sales
9.28
PEG Ratio
6.44
Dividend Yield
0.81%
ROCE (Latest)
45.14%
ROE (Latest)
21.01%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-4What is not working for the Company
PAT(Q)
At Rs 131.30 cr has Fallen at -15.2%
DEBTORS TURNOVER RATIO(HY)
Lowest at 24.96 times
Loading Valuation Snapshot...
Here's what is not working for Dr Lal Pathlabs
Profit After Tax (PAT) - Quarterly
At Rs 131.30 cr has Fallen at -15.2%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Debtors Turnover Ratio- Half Yearly
Lowest at 24.96 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
